University of Arizona
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arizona sits in the top decile of US sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count).
University of Arizona: 349 sponsored US clinical trials, 56 recruiting.
University of Arizona sponsors 349 registered US clinical trials on ClinicalTrials.gov, 56 of them currently recruiting, and 213 completed. 21 of these trials are in Phase 3-4 (later-stage) and 100 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 6 trials.
Top-decile sponsor footprint
University of Arizona ranks in the top decile of sponsors by registered trial count (#101 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
213 of 260 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
349 total, page 6 of 7
Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer
NCT02376933
Estradiol Levels in Patients Treated With Estring
NCT01923298
Extended Use of Sodium Bicarbonate in Patients With Cancer
NCT02531919
Supplemental Parenteral Nutrition in Pediatric Respiratory Failure
NCT01937884
Unilateral Massage as a Potential Treatment for Depression
NCT01937897
Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department
NCT01900847
Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method
NCT01889316
A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder
NCT01934972
Predicting Cognitive and Emotional Health From Neurocircuitry Following TBI
NCT01803048
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
NCT01800292
Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)
NCT02074449
Effects of Barefoot Running vs. in Shoes on Physiology and Mood
NCT01733381
The Sounds of Compassion: Testing How Specific Elements of Meditation Change Daily Life
NCT01643369
Sleep Intervention for Youth With Type 1 Diabetes
NCT01739712
Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL
NCT01686165
Whole Body Hyperthermia and Major Depression (MDD)
NCT01625546
Comparison of Nikkomycin Z Bioavailability Under Fed and Fasting Conditions
NCT01647256
Emergency Treatment of Coral Snake Envenomation With Antivenom
NCT01337245
Clopidogrel Resistance and Platelet Reactivity in Women Undergoing Percutaneous Coronary Intervention
NCT01796873
Social Cognition in Longstanding Psychosis
NCT01624831
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
NCT01339702
Electrophysiological Recording for Patients Receiving Deep Brain Stimulation Electrode for Treatment-resistant Obsessive-compulsive Disorder
NCT01429558
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
NCT01394211
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
NCT01385280
Diindolylmethane in Treating Patients With Breast Cancer
NCT01391689
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
NCT01351727
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
NCT01288261
Effects of Bright Light Therapy in Mild Traumatic Brain Injury
NCT01747811
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis
NCT01196286
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
NCT01570972
Use of Misoprostol for Intrauterine Device (IUD) Insertion in Nulliparous Women
NCT01001897
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States
NCT00997386
The Compassion and Attention Longitudinal Meditation Study
NCT01251341
A Grapefruit Feeding Trial in Healthy, Overweight Adults
NCT01452841
Limonene Study in Women With Breast Cancer
NCT01046929
Sleep Intervention During Acute Lung Injury
NCT01050699
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma
NCT00980395
Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
NCT00952627
The Association Between Unprotected Standing, Walking and Wound Healing in Diabetes
NCT02233179
Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women
NCT01817231
Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis
NCT01880723
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
NCT00984698
Sleep and Glucose Regulation in Youth With Type 1 Diabetes Mellitus
NCT00848822
Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer
NCT00867503
Safety and PK of Nikkomycin Z in Healthy Subjects
NCT00834184
The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women
NCT01459991
Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors
NCT03708055
Cognitive Effects of Interferon in Patients With Melanoma
NCT02074605
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
NCT00618969
Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer
NCT00701857
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 43 |
| Phase 2 | 57 |
| Phase 3 | 8 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the University of Arizona pipeline
56 recruiting of 349 indexed (16% open); 213 completed (61%).
Phase mix: 21 late (III/IV) vs 100 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arizona: open-pipeline peers nationwide
Peers matched on 349 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Arizona sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 349 trials (± recruiting share)
- Montefiore Medical Center · 345 trials · 19% recruiting
- National Institute of Mental Health (NIMH) · 343 trials · 12% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
Sponsors near 16% open enrollment (± trial volume)
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
- George Mason University · 16% recruiting · 25 trials
- University of California, San Francisco · 16% recruiting · 1,713 trials
- National Human Genome Research Institute (NHGRI) · 16% recruiting · 185 trials
Related
What to do with this University of Arizona page
349 registered trials is a research-attention snapshot, not an endorsement of University of Arizona or any single study.
- 56 of University of Arizona's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of Arizona studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Arizona pipeline card: 349 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.